Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury-Reference-Cited by-全球学者库

Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury

Published:2018-06-15 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Wang Yi-Hsin,Li Shun-An,Huang Chao-Hsin,Su Hsing-Hui,Chen Yi-Hung,Chang Jinghua T.,Huang Shiang-Suo

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference56 articles.

1. Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart.;Bohl;Am. J. Physiol. Heart Circ. Physiol.,2009

2. Regulation of signal transduction by reactive oxygen species in the cardiovascular system.;Brown;Circ. Res.,2015

3. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.;Brunet;Science,2004

4. MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.;Candas;Antioxid. Redox Signal.,2014

5. Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial.;Cao;Chin. Med. J.,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex Vivo Model to Evaluate the Antibacterial and Anti-Inflammatory Effects of Gelatin–Tricalcium Phosphate Composite Incorporated with Emodin and Lumbrokinase for Bone Regeneration;Bioengineering;2023-07-31

2. Sirt1 ameliorated cardiac autophagic flux blockage via Prx2 during myocardial ischemia/reperfusion injury;2023-03-14

3. Lumbrokinase regulates endoplasmic reticulum stress to improve neurological deficits in ischemic stroke;Neuropharmacology;2022-12

4. A New Therapeutic Trend: Natural Medicine for Ameliorating Ischemic Stroke via PI3K/Akt Signaling Pathway;Molecules;2022-11-17

5. The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications;Biochemical Journal;2022-08-31